chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea started 3-7-02 1st dose of vaccine on 3-5-02. On 3012-02, temperature of 88 degrees F (measured orally, ear: forehead strip) @ school with cramping. Diarrhea for 2-3 days-brown, green, runny.
Date of injection 3/17/09 - 1st 8 hours painful 3/19/09 rash behind knee. 3/20/09 rash to arms & legs, & then surrounding area of injection. Red papular rash. BENADRYL 25mg at HS. 1% hydrocortisone to skin an legs. Very itchy until Monday A.M. 3/23/09
My symptoms started with moderate lymph node pain in the left inguinal region, and numb left leg accompanied by episodes of feeling extreme fatigue the week after my shot.  The lymph node pain increased and the nodes became hard and rubbery(size of a peanut).   The episodes of fatigue transitioned to acute episodes of what I would call systemic shutdown accompanied by hypertension and elevated heart rate.  These would last for 12 - hours to 4 days.   After a few months of these episodes,  I developed neurological symptoms.  Paresthesia in my limbs, automatic dysfunction that included erratic heart rate and blood flow issues leaving my limbs cold, blue with involuntary spasms to envoke blood distribution.  Also had/have brain fog with a constant feeling of disorientation and couldn't sleep thru the night due to what seemed to be a blood flow problem in my brain.   Although the systemic attacks have subsided I deal with paresthesia, a numb tongue and tip of my nose, erratic heart rate, and brain-related issues daily.
Patient developed urticarial wheals on bilateral knees and buttocks on 8/1/23 AM. He took Benadryl 50mg at 1230PM that day and again at approximately 1200AM on 8/2. After taking the BEnadyrl, the swelling of the urticarial wheals improved and they were less red and seemed to fade away. At about 530 PM the wheals re-appeared but were not as itchy unitl later that night whe patient to Benadryl again. On 8/2 he was seen in office with urticarial wheals on bilat knees, bilat buttocks and bilat elbows and forearms with fewer lesions on mid to lower back and poserior aspect of lower legs. At that time patient was instructed to take Ceterizine 10mg po QD and apply cool compresses and 1% HC cream to sites BID for up to 7d in a row. Patient was also instructed that for sever itching despite Ceterizine then he can take Benadryl 25mg for breakthrough every 6 hrs.
This case was reported by a clinician and described the occurrence of possible drug interaction in a subject of unspecified age and gender who was vaccinated with TWINRIX (GlaxoSmithKline). On an unspecified date, the subject received an unspecified dose of TWINRIX (unknown route and injection site, batch number not provided). At an unspecified time after vaccination with TWINRIX, the clinician reported a potential drug interaction with TWINRIX. Despite several attempts, no further information could be obtained. At the time of reporting, the outcome of the event was unspecified. Further information was requested.
Patient was under 65 years of age (64) and received Fluad approved for patients 65 years of age and older.
Achy and flu and muscle ache above what I experience. Joint ache and fatigue lasted about 3 weeks. It wasn't minor. The pain was well above and beyond. My pain level after my bi monthly my pain level was no tolerable. My doctor had to increase my meds. Hydroxychloroquine.
intermittent hives. antihistamines have helped temporarily.  no lip swelling or SOB
Client presented at the vaccination site on 11.11.21. Client reported she received 1st dose Moderna COVID vaccine on 04.14.21 and 2nd dose Moderna COVID vaccine on 05.12.21, both are from vaccination site without any symptoms for both doses. Client is requesting to receive her Moderna COVID booster vaccine today one day earlier than she is qualifies for the Moderna COVID booster vaccine. Client reported she doesn?t have any known allergies or have any chronic illnesses. Client told she is not taking any medications. PHN submitted a medical consult via text message to clinical project coordinator, requesting to proceed with the Moderna COVID booster vaccine. Per the doctor, approval to proceed with Moderna COVID booster vaccine was obtained from medical consult team via text message from clinical project coordinator. Client received Moderna COVID booster vaccine, LOT #: 066F21A on 11.11.21 at 1511 by RN. The client did not report any symptoms during the 30-minute observation period. PHN educated client on possible adverse reactions and when to seek EMS. Client verbalized understanding. Client left vaccination site at 1541 unassisted and with a steady gait.
Redness, swelling, large knot/bump in arm at injection site about 2 in in diameter, Pain in arm when touched or when I move it. headache & fatigue
Case number PHEH2013US019963, is an initial spontaneous report received from a medical assistant on 20 SEP 2013. This report refers to a 15-year-old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: M12092), intramuscularly on an unspecified date, which was exposed to temperature up to 51F for a time of 90 minutes on 19 SEP 2013. No adverse event was reported following this administration error.
This spontaneous report was received from a registered pharmacist refers to a male patient of unknown age who on an unknown date, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on an unknown date, the patient developed red bumps following receipt of a dose of ZOSTAVAX. No treatment information was reported. At the time of the report, the patient's outcome was unknown. It was unspecified if the patient sought medical attention. Additional information has been requested.
I had shortness of breath. I was cutting brush and I thought I was out of shape. It continued so I went to see the cardiologist that I went previously to for my stint in 2014 to make sure there wasn't anything wrong and nothing was clogged up. So we did an echocardiogram and I asked how it was. He said it didn't look too good. My fraction wasn't very good 1/5 and mine was down to a 25. We figured we'd go take a look, he said it was clean and that I just had a weak heart. I did a follow up at another department at the same clinic and cut back on lamotrigine (in Neurology). There was a warning for the lamotrigine that it could cause heart problems. My fraction went from 25 to 43 (being good) for the 2nd echocardiogram. Got bundle branch block, heart pumping at same speed, but the electrical current on one side takes another second to pump. Also had blood pressure issues and they put me on medication but I wasn't able to tolerate that medication. Spent 3 hours at the hospital due to the medicine and now I've been drinking lots of water and pressure had been better. Recently did a Holter monitor and exercise and the blood pressure and oxygen have been better. Going to look at heart issues at the clinic along with epilepsy. Also checking out the medication I was taking Lamotrigine to see if this medication has also played a part in the health issues. Unsure at this time if it was in relation to that or Moderna, unsure at this time.
Swollen armpit/lymph nodes in the arm where shot was given.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 17Apr2021 at 11:15 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Apr2021, the patient experienced swollen armpit/ lymph nodes in the arm where shot was given. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of both the event swollen armpit/ lymph nodes in the arm where shot was given was unknown at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient expressed anxiety and a headache before vaccination, but was able to ambulate to the waiting area. After about 5-10 minutes, she slumped in her chair, then fell to the floor. She seemed to hit her head on the concrete floor. She was unresponsive at first, but had pulse and clear airway. Staff turned her on her side and protected. Her eyes were fluttering and rolling back. Within 3 minutes, she was able to respond to questions with her name, though she was disoriented. EMS was called at that time. She stated she had not eaten anything today, so she was given small sips of apple juice. After 5 more minutes, she was more oriented and responding to commands. EMS arrived and assisted her to a seated position. She was transported by EMS to hospital.
Same Day: Heart Palpitations - began a few hours after shot and lasted off for 3 days.  Occurred approx 10-15x per day. Day after Vaccine: Body Aches that lasted for 24 hours, Fever that lasted for 8 hours
Information has been received from a medical assistant and a nurse, for the Pregnancy Registry for GARDASIL, concerning a 16 year old female patient who on 22-JUL-2009 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (reporter not able to locate lot number). The patient was a "refugee" and came to the new country on 11-JUN-2009. On 16-SEP-2009, the patient was seen in Health Department had a Pregnancy test which was positive. The patient Last Menstrual Period was 07-JUL-2009. On 28-SEP-2009, the patient was vaccinated intramuscularly with the second 0.5 ml dose of GARDASIL (lot # 662518/0087Y) and concomitantly received FLUZONE (lot# U3174EA), the third dose of RECOMBIVAX HB (lot # 663313/1445X), the second dose of VAQTA (lot # 664625/0810Y) and IPOL (lot # B0476). On 28-SEP-2009, the patient was seen for latent tuberculosis and was prescribed isoniazid therapy. On 03-OCT-2009, the patient had a miscarriage and was seen in hospital. The patient was only 6 weeks pregnant at the time of miscarriage and reason for miscarriage unknown. The patient was not admitted to the hospital. On 06-OCT-2009, the patient was seen in a Pediatric Clinic and had menstrual type bleeding at that time. On 08-OCT-2009, the patient was schedule for follow-up laboratory blood tests and was to be referred to Family Planning. At the time of the report, the patient was recovering. Upon internal review, miscarry was determined to be an other important medical event. Additional information has been requested.
Onset of seizure, hospitalized, stabilized, seizure return, given Keppra, stabilized, returned again
An hour after receiving the vaccine My throat started shutting and my tongue started swelling.. I was given a shot and  5 pills to help everything go back to normal.
Moderna Booster Caused insomnia , wasn't tired all night, total awake hours was 20. Finally had interrupted 4 hours sleep.
pt recv vax 24OCT96 & devel a rash, swelling & fever w/in 24hr;sx resolved;
A report has been received from a Medical Rep concerning a 10 year old, female subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 18-Sep-2013. The patient experienced tested positive for flu (Preferred term: influenza virus test positive) which started on 03-Jan-2014 and 102 degrees F for two days (Preferred Term: Pyrexia). The outcome of the event of tested positive for flu and 102 degrees F for two days is unknown. The report was considered to be non-serious. Summary of insignificant follow-up information received by AstraZeneca/MedImmune 13-Jan-2014 from consumer: No new information to add. Corrected Report 26-Feb-2014: Case made medically unconfirmed and relationship with primary reporter added as other.
Having received 2 doses of Pfizer covid vaccine at 7 months I contracted covid; Having received 2 doses of Pfizer covid vaccine at 7 months I contracted covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2021, outcome "unknown", COVID-19 (medically significant) with onset Dec2021, outcome "unknown" and all described as "Having received 2 doses of Pfizer covid vaccine at 7 months I contracted covid". The patient was enquiring that how long after having covid she could receive the booster vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Injection Wed. afternoon.  Thursday, tired all day; in the afternoon, some mild discomfort at injection site.  There is some erythema and swelling present.  On Friday, my fatigue continues,  The injection site erythema is about 3 cm and warm to touch.  I have a low grade (99.6) fever.  I took 1 extra-strength Tylenol.
no adverse event; expired doses of VAQTA were administered; This spontaneous report was received from a medical assistant and referring to a patient of an unknown age and gender.  The patient's medical history, concurrent conditions, drugs reactions or allergies and concomitant medication were not provided.  On 18-JUN-2022, the patient was vaccinated with an expired dose of  hepatitis A vaccine, inactivated (VAQTA), intramuscular injection, at a dose of 0.5 milliliter once, lot number T031201, expiration date: 14-JUN-2022 (expired product administered), (strength, anatomical location of administration and route of administration were not provided) for prophylaxis.  It was stated that the patient had no adverse effects or symptoms from this dose. It was also mentioned that there was no previous temperature excursion.  This is one 6 reports received from the same reporter. ; Sender's Comments:  US-009507513-2206USA006941: US-009507513-2206USA007065: US-009507513-2206USA007033: US-009507513-2206USA006900: US-009507513-2206USA006951:
The second dose of Adult Hepatitis B was administered on 11/28/2006.  Patient developed rash on abdomen and legs beginning 11/29/2006.  The rash was red 1-2 mm flat rash, diffuse.  No specific configuration mid abdomen and both legs, most prominent near ankles, spreading in upward fashion.  Patient initially given Prednisone 20 mgm, 3qdx3;1qdx3.  Also Loratadine  10 mgm i po BID prn itching.  This all occurred on 12/01/2006 with office visit and medication being ordered.  Patient initially doing better, then phoned office on 12/06/2006 to report that she began increased itching the night  before and the "red spots" became more raised.  The nurse practioner spoke with the Medical Director and he advised to keep total daily dose of prednisone at 60 mgm (patient had gradually decreased dosage).  On 12/07/2006 patient felt the red spots were improving and fading and no new spots have been noted by patient.  On 12/08/2006 patient reports rash resolving distal areas more pronounced near lower abd prox thighs.  To continue prednison 20 mgm i po BID for 10 days.  Patient seen on 12/12/2006 by Medical Director---a sed rate and CBC were drawn and sent to local hospital lab.  The rash is improving but continues to come and go.  Patient was referred to a specialist in Dermatology for consult however patient is uncertain about money for the visit as she has no health insurance. Patient given phone number for physician to schedule her appointment.
Patient states that 2 hours after vaccination she had a splitting headache, this headache lasted  36 hours. She also developed a fever of 101. She then had her blood pressure increase and went into a-fib. She thought she was going to need a cardio conversion but she didn't. She feels that the horrible headache caused the a-fib and high blood pressure but she wanted me to report this. She stated she has had high dose flu vaccines in the past with no problems.
patient was administered 0.5 ml dose of BNT162B2 by accident, more than the recommended dose of the; arm soreness; This is a spontaneous report received via Medical information team from a contactable nurse who reported similar events for 3 patients. This is the second of 3 reports. A 42 year old patient of unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on an unspecified date, at 0.5 ml single dose, for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient was administered 0.5 ml dose of BNT162B2 by accident, more than the recommended dose of the vaccine, as they thought they were administering the Moderna vaccine. Upon follow up on 07Jan2021, it was reported that a nurse in the vaccination clinic inadvertently administered 0.5 ml of the Pfizer vaccine to 3 patients. The nurse stated that the patient was fine, only experienced a little arm soreness after receiving the vaccine. The outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow up (07Jan2021 and 08Jan2021): New information received from a contactable nurse includes: patient information (patient's age added) and course information.  Follow-Up (11Feb2021): Follow-up attempts are completed. No further information is expected.  Follow-up (19Feb2021): New information from a contactable nurse includes new non serious event (arm soreness).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021010188 same reporter, event, product, different patient
Left side completely numb. Couldn't walk the next day went to a neurologist full-blown multiple sclerosis,  never had any idea that I was a carrier of M.S. the second I got the shot my body fought the shot not the MS many many lesions back neck brain and eyes on disability now I had to get the vaccine to go back to work and now I can't work because I got the vaccine. Worked 2 jobs before the covid vaccine, 7days a week. Now disability and getting half my salary. All because I couldn't go back to work without that damn vaccine.
Very tired on Sept 8. On afternoon of Sept 9, started feeling pain in right lymph node underarm.
red, hot, swollen lips; red, hot, swollen lips; red, hot, swollen lips; tingling sensation on back of neck (left side); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Jun2021 (Lot number: EW0180) at the age of 35 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Severe environmental allergies" (unspecified if ongoing); "OAS" (unspecified if ongoing); "acute asthma" (unspecified if ongoing); "obesity" (unspecified if ongoing); "chronic rhinitis" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: if Covid prior vaccination: Yes. Concomitant medication(s) included: ALLEGRA. Past drug history included: Azithromycin, reaction(s): "Allergy"; Pediazole, reaction(s): "Allergy"; Rynatan, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose 1, lot number: EW0167, vaccine location: Left arm), administration date: 14May2021, when the patient was 34 years old, for Covid-19 Immunisation, reaction(s): "panic attack", "intense itching in legs and arms". The following information was reported: LIP SWELLING (non-serious), LIP ERYTHEMA (non-serious), ORAL DISCOMFORT (non-serious), outcome "recovered with sequelae" and all described as "red, hot, swollen lips"; PARAESTHESIA (non-serious), outcome "recovered with sequelae", described as "tingling sensation on back of neck (left side)".  Additional Information: The patient was an adult (18-64 Years). The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. other medications in two weeks: Allegra 180 mg. The patient had been diagnosed with COVID-19 prior to vaccination and had not been tested post the vaccination.  Follow-up attempts are completed. No further information is expected.
2nd dose administered eight days early outside of the 4 day grace period by 4 days.   No Adverse Events noted.
Dizziness, nausea, wheezing, hoarseness, racing heart, diarrhea, headache, joint aches. (3 days of nasty flu-like symptoms)
The next day I developed a fever and over several day after I became more short of breathe. I had Covid and pneumonia in September 2020. It got worse after getting the vaccine.  I seen a Rheumatologist, and spoke to my PCP, they ordered some additional blood work and images studies . I'm still having issues.
On 10/6/99, the pt experienced swelling of her forehead. In the evening of the following day, the pt's cheeks and eyelids also swelled. The pt reported that she used hair dye on 10/3/99 and she had had a similar reaction 9 to 10 years ago following the use of hair dye. The pt reports no difficulty breathing or swallowing.
pt recvd vax & exp urticaria; tx benadryl & apap;
Pt t100 ax & devl sz @ 7PM on day recvd vax; on following day 10JUL92 11AM pt devel another sx & was taken to ER where MD believes due to proximity of time infant may have had adverse rxn to DTP;
Information has been received from a pharmacist concerning a female patient who on 10/15/01 was vaccinated IM with a 0.5 ml dose of MMRII. On 10/16/01, the physician's offices was notified of inflammation, burning and swelling at the injection site. The patient was instructed to ice the area. On 10/26/01, the patient presented to the physician's office with an infection at the injection's site . The nurse noted that the patient had a pre-exisiting bump that was the result of a prior immunization. The reporter expressed a concern with the lot. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
Lymphedema, swollen lymph nodes in left arm, armpit,  left side of chest, and lower neck. Symptoms started 8 hours after injection. Headache/migraine, body aches, fatigue started 12 hours after injection, chills started 24 hours after injection. Headache/migraine, body aches, fatigue, chills subsided 24 hours later, lymphedema/swollen lymph nodes still on going.